This transaction is expected to enhance Teva’s revenue and earnings growth profile and strengthen its core central nervous system (CNS) franchise with the addition of Auspex’s portfolio of innovative ...

Back in the early 1990s, Dave Hitz had an epiphany that would change his life: Sharing data across a network didn't have to be complicated. Slide Show: David Hitz At the time a senior engineer at ...

Teva Pharmaceutical Industries Ltd. agreed to buy Auspex Pharmaceuticals Inc. for about $3.5 billion in cash to gain drugs that curb tics and other movement disorders. Teva will begin a tender offer ...

Auspex has a chance to revive its business with the launch of a scalable network-attached storage device that lets enterprise network managers add storage to their Ethernet networks as they grow. The ...

ALEXANDRIA, Va., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Edgesource Corporation, a small business delivering innovative solutions to the public sector, announced today that it has acquired Ashburn-based ...

Teva Pharmaceutical Industries Ltd. is buying Auspex Pharmaceuticals for about $3.2 billion in a move to strengthen its position on central nervous system condition treatments. Jerusalem-based Teva ...

JERUSALEM & LA JOLLA, Calif.--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), today announced that they have entered into a ...